CONSTANCE T. ALBARRACIN, M.D., PHD
Medical Practice at Holcombe Blvd, Houston, TX
License number
Texas L5646
Category
Medical Practice
Type
Anatomic Pathology & Clinical Pathology
Address
Address
1515 Holcombe Blvd, Houston, TX 77030
Phone
(713) 792-6161
(713) 792-2991
(713) 792-2991
Personal information
See more information about CONSTANCE T. ALBARRACIN at radaris.comName
Address
Phone
3702 Audley St, Houston, TX 77098
Houston, TX
2520 Robin Hood Ct, Houston, TX 77005
3702 Audley St, Houston, TX 77098
Professional information
See more information about CONSTANCE T. ALBARRACIN at trustoria.com
Researcher At Md Anderson Cancer Center
Researcher At Md Anderson Cancer Center
Position:
Researcher at MD Anderson Cancer Center
Location:
Houston, Texas Area
Industry:
Hospital & Health Care
Work:
MD Anderson Cancer Center
-
Researcher
Dr. Constance T Albarracin, Houston TX - MD (Doctor of Medicine)
Dr. Constance T Albarracin, Houston TX - MD (Doctor of Medicine)
Specialties:
Anatomic & Clinical Pathology
Address:
MD ANDERSON CANCER CENTER
1515 Holcombe Blvd, Houston 77030
(713) 792-2121 (Phone), (713) 794-5492 (Fax)
1515 Holcombe Blvd, Houston 77030
(713) 792-2121 (Phone), (713) 794-5492 (Fax)
Certifications:
Anatomic & Clinical Pathology, 2002
Awards:
Healthgrades Honor Roll
Languages:
English
Hospitals:
MD ANDERSON CANCER CENTER
1515 Holcombe Blvd, Houston 77030
The University of Texas M.D. Anderson Cancer Center
1515 Holcombe Blvd, Houston 77030
1515 Holcombe Blvd, Houston 77030
The University of Texas M.D. Anderson Cancer Center
1515 Holcombe Blvd, Houston 77030
Education:
Medical School
University Of Santo Tomas
University Of Santo Tomas
Constance T Albarracin, Houston TX
Constance T Albarracin, Houston TX
Specialties:
Pathologist
Address:
1515 Holcombe Blvd, Houston, TX 77030
Board certifications:
American Board of Pathology Certification in Clinical Pathology (Pathology)
Micro-Rnas As Markers For Tumor Progression
Micro-Rnas As Markers For Tumor Progression
US Patent:
2011027, Nov 10, 2011
Filed:
Oct 21, 2009
Appl. No.:
13/125277
Inventors:
Rajyalakshmi Luthra - Missouri City TX, US
Madan Luthra - Missouri City TX, US
Constance Albarracin - Houston TX, US
Madan Luthra - Missouri City TX, US
Constance Albarracin - Houston TX, US
Assignee:
THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SY STEM - Austin TX
International Classification:
C40B 30/04, C12Q 1/02, C12Q 1/68
US Classification:
506 9, 435 614, 435 61, 435 611, 435 29, 435 612
Abstract:
Disclosed are methods for diagnosing cancer or dysplasia in a sample of tissue, involving testing cells of the sample to assess whether miR-196a expression in cells of the sample is greater than a reference, wherein a greater expression of miR-196a in cells of the sample compared to the reference is indicative of cancer or dysplasia. The cancer or dysplasia may be esophageal cancer or esophageal dysplasia. Also disclosed are method for diagnosing cancer or dysplasia in a sample of tissue, comprising testing cells of the sample to assess whether the expression of ANXA1, KRT5, SPRR2C, or S100A9 in cells of the sample is reduced compared to a reference control, wherein said reduced expression in cells of the sample compared to the reference control is indicative of cancer or dysplasia. Also disclosed are kits and methods involving kits for the diagnosis of cancer or dysplasia.